<DOC>
	<DOC>NCT00200473</DOC>
	<brief_summary>A study to determine the safety, efficacy and superiority of nebivolol to placebo for the treatment of elevated blood pressure in patients with mild to moderate hypertension.</brief_summary>
	<brief_title>A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients</brief_title>
	<detailed_description>This study was a multi-center, multi-national, randomized, double-blind, parallel group, placebo-controlled study of nebivolol over a range of doses in patients with mild to moderate hypertension. The study consisted of 2 phases: screening/washout/single-blind placebo run-in and 2) randomization/double-blind treatment. Patients had 7 scheduled clinic visits during the study.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>An average sitting diastolic blood pressure of greater then or equal to 95 mmHg and less then or equal to 109 mmHg at baseline Recent myocardial infarction or stroke Secondary hypertension Contraindications to betablocker therapy or discontinuation of prior antihypertensive agents Pregnancy, nursing or women of childbearing age not using appropriate contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Nebivolol</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Beta-Blockers</keyword>
</DOC>